New research has suggested that individuals who suffer from both heart failure and type II diabetes may benefit from taking daily aspirin. The study reviewed medical records from more than 12,000 indi ...
All Cancer News
Researchers at MRCCTU at UCL join a major research project launched to crack aspirin’s anti-cancer properties
Cancer Research UK launched an international study today, to answer the final questions before aspirin could be recommended to reduce cancer risk. Studies have estimated that widespread use of low-do ...
Add-Aspirin recruitment continues in India!
Add-Aspirin is now open at 11 centres in India:
- Tata Memorial Hospital, Mumbai
- Chennai Breast Centre
- Jehangir Clinical Development Centre, Pune
- Tata Medical Centre, Kolkata
- Meditrina Institute of Medical Sciences, Nashik
- Shatabdi Hospital, Nagpur
- Vikram & Fortis Hospital, Bengaluru
- Cancer Institute (WIA), Chennai
- Regional Cancer Centre, Trivandrum
- Meenakshi Mission Hospital, Madurai
- IndoAmerican Cancer Centre, Hyderabad
New study reports: “No benefit of Celecoxib in Breast Cancer Patients”
New study reports: “No benefit of Celecoxib in Breast Cancer Patients”A recent study looking at the use of the non-steroidal anti-inflammatory drug (NSAID), celecoxib, in participants who have had sur ...
Further evidence of the benefits of taking aspirin for people with bowel cancer
A recent report has provided further evidence to suggest that individuals who take aspirin following a diagnosis of colorectal (bowel) cancer are less likely to die from their cancer. The study included 2400 individuals with bowel cancer from Australia, Canada and the U.S...
News and Resources